Evogene Revenue and Competitors
Estimated Revenue & Valuation
- Evogene's estimated annual revenue is currently $21.4M per year.
- Evogene's estimated revenue per employee is $175,328
- Evogene's total funding is $94.5M.
Employee Data
- Evogene has 122 Employees.
- Evogene grew their employee count by -10% last year.
Evogene's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Agronomist | Reveal Email/Phone |
2 | VP HR | Reveal Email/Phone |
3 | VP Legal | Reveal Email/Phone |
4 | EVP Technology | Reveal Email/Phone |
5 | Head MicroBoost AI | Reveal Email/Phone |
6 | VP Experimental Technologies | Reveal Email/Phone |
7 | VP R&D AgSeeds | Reveal Email/Phone |
8 | VP Computational Technologies | Reveal Email/Phone |
9 | Head Bioinformatics | Reveal Email/Phone |
10 | EVP Technology | Reveal Email/Phone |
Evogene Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is Evogene?
Evogene (NASDAQ, TASE: EVGN) is a leading biotechnology company developing novel products for major life science markets through the use of a unique predictive biology platform incorporating deep scientific understandings and advanced computational technologies. This platform is utilized by the Company to discover and develop innovative Ag-Chemical, Ag-Biological and Ag-Seed products (GM and non GM), and by two subsidiaries; Evofuel, focused on castor seeds, and Biomica, focused on human microbiome therapeutics. Through its collaborations with world-leading agricultural companies such as BASF, Bayer, DuPont, Monsanto and Syngenta, Evogene has licensed genes, small molecules and microbes to partners under milestone and royalty bearing agreements. For more information, please visit www.evogene.com
keywords:N/A
$94.5M
Total Funding
122
Number of Employees
$21.4M
Revenue (est)
-10%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Evogene News
Evogene (TSE:EVGN Get Rating)'s stock had its buy rating reaffirmed by equities research analysts at Echelon Wealth Partners in a...
Evogene Ltd (EVGN) stock has fallen -74.89% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy.
Evogene Ltd (EVGN) is up 3.51% today. Overall Score - 40. EVGN has an Overall Score of 40. Find out what this means to you and get the rest of...
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $24.5M | 122 | 16% | $61M |
#2 | $35.4M | 122 | 8% | N/A |
#3 | $27.7M | 122 | 27% | N/A |
#4 | $21M | 122 | 12% | N/A |
#5 | $19.5M | 122 | 5% | N/A |